References
- Masseria C, Martin CK, Krishnarajah G, Becker LK, Buikema A, Tan TQ. Incidence and burden of pertussis among infants less than 1 year of age. Pediatr Infect Dis J. 2017;36(3):e54–61. doi:10.1097/INF.0000000000001440.
- Skoff TH, Hadler S, Hariri S. The epidemiology of nationally reported pertussis in the United States, 2000–2016. Clin Infect Dis. 2019;68:1634–40. doi:10.1093/cid/ciy757.
- Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, Clark TA. Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67:1–44.
- World Health Organization. Pertussis vaccines: WHO position paper—September 2015. Wkly Epidemiol Rec. 2015;90:433–58.
- Gov.UK. Guidance vaccination against pertussis (whooping cough) for pregnant women. [accessed 2021 May 31]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/897039/Pertussis_vaccination_for_pregnant_women_2020.pdf.
- Government of Canada. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI): update on immunization in pregnancy with tetanus toxoid, reduced diphtheria toxoid and reduced acellular pertussis (Tdap) vaccine. [accessed 2021 Mar 30]. https://www.canada.ca/en/public-health/services/publications/healthy-living/update-immunization-pregnancy-tdap-vaccine.html.
- Australian Government. Department of health. The Australian Immunisation Handbook: Pertussis (whooping cough). [accessed 2021 Mar 30]. https://immunisationhandbook.health.gov.au/vaccine-preventable-diseases/pertussis-whooping-cough.
- Walls T, Graham P, Petousis-Harris H, Hill L, Austin N. Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study. BMJ Open. 2016;6(1):e009536. doi:10.1136/bmjopen-2015-009536.
- Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521–28. doi:10.1016/S0140-6736(14)60686-3.
- National Institute of Infectious Diseases, Center for Epidemiology of Infectious Diseases and Bacteria Division II. Epidemiology of pertussis-reported cases in Japan based on overall reported surveillance (updated information). Epidemiology Week 1–52. 2019 [accessed 2021 Mar 30]. https://www.niid.gchapo.jp/niid/ja/pertussis-m/pertussis-idwrs/9463-pertussis-20200306.html. (in Japanese).
- Ujiie M, Tsuzuki S, Suzuki M, Ota M, Suzuki T, Nomoto H, Yamamoto K, Saito S, Kokaze A, Kinoshita N, et al. Safety of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine in adults in Japan. Jpn J Infect Dis. 2021 Jan 29. doi:10.7883/yoken.JJID.2020.947. Online ahead of print.
- Kitano T, Onishi T, Takeyama M, Shima M. Questionnaire survey on maternal pertussis vaccination for pregnant women and mothers in Nara prefecture, Japan. Hum Vaccin Immunother. 2020;16(2):335–39. doi:10.1080/21645515.2019.1651000.
- Ohkuchi A, Baba Y, Matsubara S. Maternal medical checkup system in the region: effect of obstetrical practice guideline 2008 Japan on several obstetrical practice. J Jpn Soc Perinatal Neonatal Med. 2010;46:1155–56. (in Japanese).